ResearcherUniversity of LiverpoolActive in the last 2 years
Lawrence N. Barrera
Matched on ORCID iD 0009-0000-1908-162X; OpenAlex author ID A5023002526. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 30
2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 2 papers · 2024: 1 paper · 2025: none · 2026: 1 paper
Papers 6
- NQO1 as a predictor of response to adjuvant GemCap treatment for pancreatic cancer. Co-author DOI 10.1093/jnci/djaf345↗
- Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis. Co-author DOI 10.1158/0008-5472.can-23-3419↗
- Inclusion of cancer-associated fibroblasts in drug screening assays to evaluate pancreatic cancer resistance to therapeutic drugs. First author DOI 10.1007/s13105-021-00857-2↗
- The role of microRNAs in the modulation of cancer-associated fibroblasts activity during pancreatic cancer pathogenesis. Co-author DOI 10.1007/s13105-022-00899-0↗
- S100A8 and S100A9 proteins form part of a paracrine feedback loop between pancreatic cancer cells and monocytes. Co-author DOI 10.1186/s12885-018-5161-4↗
- UHRF1 regulation of the Keap1-Nrf2 pathway in pancreatic cancer contributes to oncogenesis. Co-author DOI 10.1002/path.4665↗
Closest collaborators
The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Eithne Costello · 5 shared papers, 2016–2026 · strength 0.82
- Paper Inclusion of cancer-associated fibroblasts in drug screening assays to evaluate pancreatic cancer resistance to therape… DOI 10.1007/s13105-021-00857-2↗
- Paper The role of microRNAs in the modulation of cancer-associated fibroblasts activity during pancreatic cancer pathogenesis. DOI 10.1007/s13105-022-00899-0↗
- Paper NQO1 as a predictor of response to adjuvant GemCap treatment for pancreatic cancer. DOI 10.1093/jnci/djaf345↗
- Pedro Antonio Pérez-Mancera · 3 shared papers, 2023–2026 · strength 0.61
- Paper The role of microRNAs in the modulation of cancer-associated fibroblasts activity during pancreatic cancer pathogenesis. DOI 10.1007/s13105-022-00899-0↗
- Paper NQO1 as a predictor of response to adjuvant GemCap treatment for pancreatic cancer. DOI 10.1093/jnci/djaf345↗
- Paper Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis. DOI 10.1158/0008-5472.can-23-3419↗
- Camino Bermejo‐Rodríguez · 2 shared papers, 2023–2024 · strength 0.40
- John P. Neoptolemos · 3 shared papers, 2016–2026 · strength 0.34
- Paper NQO1 as a predictor of response to adjuvant GemCap treatment for pancreatic cancer. DOI 10.1093/jnci/djaf345↗
- Paper S100A8 and S100A9 proteins form part of a paracrine feedback loop between pancreatic cancer cells and monocytes. DOI 10.1186/s12885-018-5161-4↗
- Paper UHRF1 regulation of the Keap1-Nrf2 pathway in pancreatic cancer contributes to oncogenesis. DOI 10.1002/path.4665↗
- William Greenhalf · 3 shared papers, 2016–2026 · strength 0.34
- Paper NQO1 as a predictor of response to adjuvant GemCap treatment for pancreatic cancer. DOI 10.1093/jnci/djaf345↗
- Paper S100A8 and S100A9 proteins form part of a paracrine feedback loop between pancreatic cancer cells and monocytes. DOI 10.1186/s12885-018-5161-4↗
- Paper UHRF1 regulation of the Keap1-Nrf2 pathway in pancreatic cancer contributes to oncogenesis. DOI 10.1002/path.4665↗
- Lucy S. Oldfield · 2 shared papers, 2018–2026 · strength 0.30
- Sarah Brumskill · 1 shared paper, 2023 · strength 0.24
- Paula Ghaneh · 1 shared paper, 2026 · strength 0.22
- Thilo Hackert · 1 shared paper, 2026 · strength 0.22
- Christoph Springfeld · 1 shared paper, 2026 · strength 0.22
- Kate Murray · 1 shared paper, 2026 · strength 0.22
- Dylan Williams · 1 shared paper, 2026 · strength 0.22
- Christoph W. Michalski · 1 shared paper, 2026 · strength 0.22
- Christopher Michael Halloran · 1 shared paper, 2026 · strength 0.22
- Daniel H. Palmer · 1 shared paper, 2026 · strength 0.22
- Giuseppina Caligiuri · 1 shared paper, 2024 · strength 0.16
- Joaquín Araos Henríquez · 1 shared paper, 2024 · strength 0.16
- Thomas Knösel · 1 shared paper, 2024 · strength 0.16
- Robert Grützmann · 1 shared paper, 2024 · strength 0.16
- Albrecht Neeße · 1 shared paper, 2024 · strength 0.16
- Youngkyu Park · 1 shared paper, 2024 · strength 0.16
- Christian P. Pilarsky · 1 shared paper, 2024 · strength 0.16
- David Arthur Tuveson · 1 shared paper, 2024 · strength 0.16
- Daniel Öhlund · 1 shared paper, 2024 · strength 0.16
- Giulia Biffi · 1 shared paper, 2024 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.